Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial) (Q84974486)
Jump to navigation
Jump to search
scientific article published on 01 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial) |
scientific article published on 01 September 2012 |
Statements
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial) (English)
Anders Bruun Mathiasen
Erik Jørgensen
Abbas Ali Qayyum
Mandana Haack-Sørensen
Jens Kastrup
1 September 2012